Dr. Reddy's Laboratories

We are excited to welcome Peter Bartley who joins us as Head of Commercial for Consumer Healthcare. Peter will be part of our team focusing on our newly acquired global portfolio of Nicotine Replacement Therapy brands from Haleon plc, including the global market-leading brand, Nicotinell. #WeAreDrReddys #GoodHealthCantWait #DrReddysEurope #DrReddysConsumerHealthcare

Observing the birth anniversary of a great world leader, Mahatma Gandhi, who guided India towards independence through the ideals of non-violence and self-reliance. Accessible medicines is our way of contributing to the vision of peace, self-reliance and empowerment. In the year that we observed #40YearsOfDrReddys, we remember the ideals of Mahatma Gandhi with our aim to touch over 1.5 billion patients by 2030, and Indian pharma's aspiration to grow into a $400 billion industry by 2047. #GandhiJayanti #InternationalDayofNonViolence #MahatmaGandhi #GoodHealthCantWait #WeAreDrReddys

Pleased to share that we have now completed the acquisition of the Nicotine Replacement Therapy (NRT) portfolio of Haleon plc outside the United States. Our acquired portfolio consists of Nicotinell, a global leader in the NRT category with an extensive footprint in over 30 countries spanning Europe, Asia including Japan, and Latin America, and local market-leading brand names of the product – Nicabate in Australia, Thrive in Canada, and Habitrol in New Zealand and Canada. The portfolio is inclusive of all formats such as lozenge, patch, gum as well as pipeline products, in all applicable global markets outside of the United States. Nicotinell is the second biggest brand globally (excluding the United States) in the NRT category. NRT is recommended by the ‘World Health Organization Model List of Essential Medicines’ for nicotine use disorders. The acquisition of this global portfolio of consumer healthcare products is a significant and logical extension of our efforts in consumer healthcare (nutrition and OTC wellness) in recent years, and of our purpose of ‘Good Health Can’t Wait’. We have been steadily building our OTC presence in various markets and investing in our capabilities, including a recent joint venture with Nestlé India. As a business, consumer healthcare is a growing and sustainable business with favourable long-term trends. This acquisition is an ideal anchor to continue to build our global consumer healthcare OTC business. #WeAreDrReddys #GoodHealthCantWait

Don't miss our Biologics team at Booth #24A41 from October 8th to 10th! #DrReddysBiologics #GoodHealthCantWait #WeAreDrReddys #CPHI2024

"Beekeeping and farming are inextricably linked, as bees play a crucial role in pollination, which increases the yield of crops." By integrating beekeeping with agriculture, we're boosting crop productivity and providing farmers with sustainable livelihoods. Satya Aruna, our Technical Associate for Biodiversity writes on the symbiotic relationship between bees and crops: https://lnkd.in/gsuGhkQs #Sustainability #Beekeeping #Agriculture #Farmers #Pollination #RuralLivelihoods #SDGs #DrReddysFoundation

🎤 Our CEO, Dr. Murali Ramachandra, will be presenting Aurigene Oncology Limited’s innovative approach to developing Pan-KRAS degraders at the 22nd Annual Discovery on Target conference, to be held from 🗓 Sept 30th – Oct 3rd in 📍 Boston, MA.   🔎 Leveraging our proprietary Directed Neo-substrate Degrader (DNsD) platform, the lead molecule has been optimized to effectively degrade all tested mutant KRAS proteins while maintaining exquisite selectivity over HRAS and NRAS. The nomination of the development candidate is anticipated in 🗓 Q4 2024. The conference is organized by Cambridge Healthtech Institute #BostonDOT24 #Cancer #Oncology #KRAS #PlatformTechnologies #Degraders #mutations #CancerTargets #CancerResearch #precisiononcology #OncologyTargets #OncologyPipeline #SmallMolecules #Immunooncology #DrugDiscovery #CancerTreatment #OncologyConferences #Networking #BusinessDevelopment #Partnerships #BusinessDevelopmentProfessionals #Boston #USA #Healthcare #Pharma #Pharmaceuticals

🌍 BPI Boston 2024: A Global Celebration of Biotechnology and Pharmaceutical Innovation! 🌍 This week, we had an incredible time at BPI Boston 2024, where the world's leading minds in biopharma came together to explore, innovate, and collaborate! 🌟 The conference was a dynamic platform for discussing the fascinating journey of small and large molecules from the laboratory to the market. 🔬 Key Highlights: 🖊 Insightful Sessions: Engaging talks on the latest advancements in small and large-molecule therapeutics at various stages from discovery to commercialization. 🖊 Interactive Panels: Experts shared their experiences and strategies for overcoming challenges in drug development and regulatory pathways. 🖊 Customer Engagement: We were thrilled to connect with so many of you and discuss your novel molecule needs and how we can accelerate their journey from lab to market. 🖊 Networking Opportunities: The event facilitated meaningful connections, fostering collaborations that will drive the industry forward. 🖊 A heartfelt thank you to all the attendees, speakers, and organizers for making this convention a tremendous success. Let’s continue to break new ground in biopharma together! 🚀 Now, our discovery team is gearing up for the next exciting event: Discovery on Target 2024! 🎉 Join us at Booth #424 from September 30 to October 3 at the Sheraton Boston, where we will showcase our latest advancements in biologics and small molecules. With Aurigene's comprehensive capability to support from discovery to commercial-scale cGMP manufacturing, expertise across diverse biologics modalities, and small molecule discovery in both chemistry and biology, we are well suited to taking your molecule from lab to market faster. Write to us at contactapsl@aurigeneservices.com to book a meeting with our experts attending the DOT conference in Boston. Meet our experts by visiting Booth #424 or drop an email to schedule a meeting. See you soon! #BPIBoston #BiotechInnovation #DrugDevelopment #Biopharma #Networking #DiscoveryOnTarget #DOT2024 #Biologics #SmallMolecules #LabToMarket #Aurigene #PharmaConference Roger Lias Jenny Yip

Thank you #ETNowCFOStrategySummit2024 for this wonderful opportunity to interact with stalwarts of the CFO fraternity. The agenda involved innovation, AI, compliance, talent strategy, automation, insights, working capital efficiency etc, the most important insight is execution with agility and right mindset. Special thanks to my co panelist Kumar Ayashkanta and Rachesh Kotak for an engaging session on innovation, treasury and tax. #Etnowcfosummit2024 #drreddys #cfo #cfosummit2024 #innovation #financeleadership #IIA #riskmanagement #globalbanking

As we get closer to CPHI Milan we take a closer look at some of the conference tracks on site! Anil Kane, Ph.D., MBA from Thermo Fisher Scientific speaks to us about the Manufacturing 5.0 track, which they are sponsoring this year. The track explores the ever-evolving CDMO landscape, and what the role of AI and machine learning will look like in the future of manufacturing 🏭 The track features panels and presentations from globally-leading experts in the field, including from Medicines for Europe, Thermo Fisher Scientific, and Dr. Reddy's Laboratory to name just a few. See Kane's take on what to expect from the conference theatre in the following interview: https://ow.ly/sM0R50Tvh99 Don't miss the Manufacturing 5.0 track in Hall 5 of the Fiera Milano this October. #CPHIMilan #Manufacturing5.0 #CDMO #CMO #pharma #thoughtleader

I am beyond elated and honored to be the Winner of the Brand category in the WeQual Awards, Asia-Pacific 2024! This journey of leadership assessment, CEO interview has been incredibly reflective and rewarding. I am grateful for the opportunity to be recognized alongside so many talented women leaders. Being part of the WeQual Executives community that recognises women leaders in senior leadership is inspiring! Looking forward to keep pushing boundaries and making a positive impact! https://lnkd.in/gtSj6WGP #WeQual #WomenInBusiness #Leadership #drreddys #Stem #diversity #strategy #branding Katie Litchfield WeQual Dr. Reddy's Laboratories